Novelos Therapeutics Presents Diapeutic Technology Platform At EMIT: ...

"LIGHT, HOT and GLOW2 were designed to exploit a feature shared by most, if not all, cancer cells including cancer stem cells, which results in the selective uptake and prolonged accumulation of our proprietary, small-molecule delivery vehicle in a wide range of malignant tumors compared with normal tissues," said Dr.

http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=20765